BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14996622)

  • 1. Treating chromoblastomycosis with systemic antifungals.
    Bonifaz A; Paredes-Solís V; Saúl A
    Expert Opin Pharmacother; 2004 Feb; 5(2):247-54. PubMed ID: 14996622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both.
    Bonifaz A; Martínez-Soto E; Carrasco-Gerard E; Peniche J
    Int J Dermatol; 1997 Jul; 36(7):542-7. PubMed ID: 9268758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
    Gupta AK; Taborda PR; Sanzovo AD
    Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromoblastomycosis.
    Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
    Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chromoblastomycosis with terbinafine: experience with four cases.
    Bonifaz A; Saúl A; Paredes-Solis V; Araiza J; Fierro-Arias L
    J Dermatolog Treat; 2005 Feb; 16(1):47-51. PubMed ID: 15897168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
    Queiroz-Telles F; Esterre P; Perez-Blanco M; Vitale RG; Salgado CG; Bonifaz A
    Med Mycol; 2009 Feb; 47(1):3-15. PubMed ID: 19085206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy.
    Kullavanijaya P; Rojanavanich V
    Int J Dermatol; 1995 Nov; 34(11):804-7. PubMed ID: 8543418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
    Hu Y; Qi X; Sun H; Lu Y; Hu Y; Chen X; Liu K; Yang Y; Mao Z; Wu Z; Zhou X
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
    Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
    Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
    Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
    Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M; Ruíz LF; Castillo A; Arenas R; Vega-Memije ME; Xicohtencatl-Cortes J; Espinoza-Rivera M; Hernández-Castro R
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
    Yang Y; Hu Y; Zhang J; Li X; Lu C; Liang Y; Xi L
    Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fonsecaea pedrosoi-induced chromoblastomycosis: about a case].
    Baline K; Hali F
    Pan Afr Med J; 2018; 30():187. PubMed ID: 30455816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHROMOBLASTOMYCOSIS: A NEGLECTED TROPICAL DISEASE.
    Queiroz-Telles F
    Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):46-50. PubMed ID: 26465369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chromoblastomycosis due to Fonsecaea pedrosoi with low-dose terbinafine.
    Sevigny GM; Ramos-Caro FA
    Cutis; 2000 Jul; 66(1):45-6. PubMed ID: 10916691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP; Li W; Huang WM; Zhou Y; Fan YM
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromoblastomycosis in India: Review of 169 cases.
    Agarwal R; Singh G; Ghosh A; Verma KK; Pandey M; Xess I
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005534. PubMed ID: 28771470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
    Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
    Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.
    Queiroz-Telles F; Purim KS; Fillus JN; Bordignon GF; Lameira RP; Van Cutsem J; Cauwenbergh G
    Int J Dermatol; 1992 Nov; 31(11):805-12. PubMed ID: 1330949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septic arthritis and osteomyelitis due to the chromoblastomycosis agent Fonsecaea pedrosoi.
    De Guzman L; Perlman DC; Hubbard CE
    Am J Orthop (Belle Mead NJ); 2012 Jul; 41(7):328-31. PubMed ID: 22893884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.